CHANGES IN THE EEG POWER SPECTRUM AFTER MIDAZOLAM ANESTHESIA COMBINED WITH RACEMIC OR S-(+)KETAMINE

被引:23
作者
HERING, W
GEISSLINGER, G
KAMP, HD
DINKEL, M
TSCHAIKOWSKY, K
RUGHEIMER, E
BRUNE, K
机构
[1] UNIV ERLANGEN NURNBERG,DEPT EXPTL & CLIN PHARMACOL & TOXICOL,D-91054 ERLANGEN,GERMANY
[2] CENT HOSP ST JUERGEN STR,DEPT ANAESTHESIOL,BREMEN,GERMANY
关键词
EEG POWER SPECTRUM; MEDIAN FREQUENCY; MIDAZOLAM RACEMIC KETAMINE; MIDAZOLAM S-(+) KETAMINE;
D O I
10.1111/j.1399-6576.1994.tb03984.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Changes in the EEG power spectrum were studied in 50 patients (ASA status I or II), receiving either 2 mg . kg(-1) of racemic ketamine or 1 mg . kg(-1) of S-(+) ketamine in a randomized and double-blind manner after prior administration of 0.1 mg . kg(-1) of midazolam. The patients receiving intramuscular premedication with midazolam about 45 minutes prior to induction of anaesthesia showed, in a deliberately quiet environment and mostly in the early morning, a delta dominated EEG (56% delta power) with a reduced alpha peak (17% alpha power) and an average median of 4 Hz as the baseline findings of the EEG power spectrum. The intravenous administration of midazolam led to activation of the lower beta range (13-18 Hz) and the subsequent injection of ketamine caused an increase in activity in the fast beta range (21-30 Hz), both being accompanied by a reduction of delta power from 56% to 40%. Correspondingly, an increase in the median frequency was noted. Causing nearly the same changes in EEG, S-(+) ketamine was confirmed to be twice as potent as racemic ketamine.
引用
收藏
页码:719 / 723
页数:5
相关论文
共 15 条
[1]   25 YEARS OF KETAMINE - A REPORT OF AN INTERNATIONAL MEETING [J].
DUNDEE, JW .
ANAESTHESIA, 1990, 45 (02) :159-160
[2]   PHARMACOKINETICS AND PHARMACODYNAMICS OF KETAMINE ENANTIOMERS IN SURGICAL PATIENTS USING A STEREOSELECTIVE ANALYTICAL METHOD [J].
GEISSLINGER, G ;
HERING, W ;
THOMANN, P ;
KNOLL, R ;
KAMP, HD ;
BRUNE, K .
BRITISH JOURNAL OF ANAESTHESIA, 1993, 70 (06) :666-671
[3]  
MELISKA CJ, 1980, J PHARMACOL EXP THER, V212, P198
[4]   KETAMINE - AN UPDATE ON THE 1ST 25 YEARS OF CLINICAL-EXPERIENCE [J].
REICH, DL ;
SILVAY, G .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1989, 36 (02) :186-197
[5]   COMPARATIVE PHARMACOLOGY OF OPTICAL ISOMERS OF KETAMINE IN MICE [J].
RYDER, S ;
WAY, WL ;
TREVOR, AJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 49 (01) :15-23
[6]  
SCHULTZ A, 1990, ANAESTHESIST, V39, P222
[7]   PHARMACODYNAMIC MODELING OF THE EEG EFFECTS OF KETAMINE AND ITS ENANTIOMERS IN MAN [J].
SCHUTTLER, J ;
STANSKI, DR ;
WHITE, PF ;
TREVOR, AJ ;
HORAI, Y ;
VEROTTA, D ;
SHEINER, LB .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1987, 15 (03) :241-253
[8]   EFFECTS OF KETAMINE ON ELECTROENCEPHALOGRAPH [J].
SCHWARTZ, MS ;
VIRDEN, S ;
SCOTT, DF .
ANAESTHESIA, 1974, 29 (02) :135-140
[9]  
SCHWILDEN H, 1984, MIDAZOLAM ANASTHESIO, P41
[10]  
TATSUNO J, 1990, STATUS OF KETAMINE IN ANESTHESIOLOGY, P167